Cell Reports Medicine

Cell Reports Medicine is a prestigious open-access journal published by Cell Press, a leading imprint of Elsevier, dedicated to publishing cutting-edge translational and clinical research. With an ISSN of 2666-3791 and an abbreviation of CELL REP MED, the journal has rapidly established itself as a premier venue for high-impact studies that bridge the gap between fundamental biomedical discoveries and tangible medical applications. Its scope encompasses a broad spectrum of topics, including innovative therapeutic strategies, biomarker discovery, disease mechanisms, clinical trial results, and precision medicine, with a strong emphasis on studies that demonstrate direct relevance to human health and disease. The journal welcomes a variety of article types, including original research articles, reviews, reports, and resources, all of which must present robust, reproducible data and clear translational potential. The target audience includes academic researchers, clinical investigators, pharmaceutical and biotechnology professionals, and healthcare practitioners seeking the latest evidence-based advancements. A defining feature of Cell Reports Medicine is its fully open-access model, ensuring that all published content is freely available to the global scientific community, thereby maximizing dissemination and impact. The journal’s exceptional standing in the field is reflected by its 2026 Journal Citation Reports Impact Factor of 14.0000 and its placement in the top quartile (Q1) of its category, underscoring its role as a leading source of influential, high-quality research that drives progress from bench to bedside.